Entera Bio Ltd

자세한 내용은 Entera Bio Ltd 회사

Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

회사 정보

종목 코드 ENTX

회사 이름Entera Bio Ltd

상장일Jun 28, 2018

CEOMs. Miranda Jayne Toledano

직원 수18

유형Ordinary Share

회계 연도 종료Jun 28

주소Hadassah / Jerusalem Bio

도시JERUSALEM

증권 거래소NASDAQ Capital Market Consolidated

국가Israel

우편 번호9112002

전화97225327151

웹사이트https://enterabio.com/

종목 코드 ENTX

상장일Jun 28, 2018

CEOMs. Miranda Jayne Toledano

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Gerald M. (Jerry) Lieberman

Independent Chairman of the Board

324.96K

--

Ms. Miranda Jayne Toledano

Chief Executive Officer, Director

291.45K

+163.16%

Mr. Sean Ellis

Independent Director

134.73K

--

Ms. Haya Taitel

Independent Director

64.65K

--

Mr. Yonatan Malca

Independent Director

47.26K

--

Mr. Gerald M. (Jerry) Ostrov

Independent Director

46.94K

--

Mr. Ron Abraham Mayron

Independent Director

--

Ms. Dana Yaacov-Garbeli

Chief Financial Officer

--

Dr. Roger J. Garceau, M.D.

Director

--

Dr. Hillel Galitzer

Chief Operating Officer

--

이름

이름/직위

직위

주식 보유

변동

Mr. Gerald M. (Jerry) Lieberman

Independent Chairman of the Board

324.96K

--

Ms. Miranda Jayne Toledano

Chief Executive Officer, Director

291.45K

+163.16%

Mr. Sean Ellis

Independent Director

134.73K

--

Ms. Haya Taitel

Independent Director

64.65K

--

Mr. Yonatan Malca

Independent Director

47.26K

--

Mr. Gerald M. (Jerry) Ostrov

Independent Director

46.94K

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Thu, Jul 17

주주

주주 유형

주주

비율

Knoll Capital Management, LLC

12.94%

OPKO Health Inc

8.50%

D.N.A Biomedical Solutions, Ltd.

8.21%

Point72 Asset Management, L.P.

5.93%

Centillion Fund Inc

5.27%

Other

59.14%

주주

비율

Knoll Capital Management, LLC

12.94%

OPKO Health Inc

8.50%

D.N.A Biomedical Solutions, Ltd.

8.21%

Point72 Asset Management, L.P.

5.93%

Centillion Fund Inc

5.27%

Other

59.14%

주주 유형

주주

비율

Corporation

21.99%

Hedge Fund

21.33%

Individual Investor

2.44%

Investment Advisor

0.70%

Research Firm

0.07%

Investment Advisor/Hedge Fund

0.05%

Venture Capital

0.02%

Other

53.41%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

44

20.97M

46.14%

-173.92K

2025Q1

48

20.87M

47.30%

+2.99M

2024Q4

45

14.59M

39.63%

+276.18K

2024Q3

44

12.66M

34.61%

+129.89K

2024Q2

43

12.40M

34.23%

+1.30M

2024Q1

39

11.33M

31.94%

+147.25K

2023Q4

38

10.84M

34.31%

+2.50M

2023Q3

40

9.31M

32.31%

-70.93K

2023Q2

42

9.22M

32.01%

-186.20K

2023Q1

42

9.45M

32.81%

-129.12K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Knoll Capital Management, LLC

5.88M

12.94%

--

Mar 31, 2025

OPKO Health Inc

3.87M

8.5%

+180.00K

+4.88%

May 08, 2025

D.N.A Biomedical Solutions, Ltd.

3.73M

8.21%

--

May 08, 2025

Point72 Asset Management, L.P.

2.70M

5.93%

-4.32K

-0.16%

Mar 31, 2025

Centillion Fund Inc

2.40M

5.27%

--

May 08, 2025

Schonfeld Strategic Advisors LLC

599.16K

1.32%

-33.16K

-5.24%

Mar 31, 2025

Parkman Healthcare Partners LLC

439.63K

0.97%

+25.90K

+6.26%

Mar 31, 2025

Lieberman (Gerald M)

324.96K

0.71%

--

May 08, 2025

Toledano (Miranda Jayne)

110.75K

0.24%

--

May 08, 2025

Northern Trust Global Investments Limited

198.83K

0.44%

-13.65K

-6.42%

Mar 31, 2025

2.086USD

Entera Bio Ltd

2.086

개요

회사

금융